Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
This text is a result of machine translation.
Related companies：
In-depth
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Apr 28, 2022 08:00 PM
Apr 18, 2022 09:14 PM
Briefing Feb 20, 2022 03:49 PM
· Healthcare
A fire broke out in a mechanical and electrical plant in Huaiyuan, Anhui Province, and local fire and public security departments are rescuing
Briefing Jan 31, 2022 10:29 AM
· Healthcare
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
Healthcare
Trautec Medical Raises Nearly CNY 200 Mn in Series A Financing Round
Trautec Medical, dedicated to developing and producing recombinant collagen-based biomaterials, will continue to focus on the innovation of biomaterials and strive to integrate resources from all sides.
Yesterday 06:12 PM
Healthcare
Preparation Developer Elite Pharmaceutical Nets Nearly CNY 100 Mn in Series B Round
This financing round will further promote the company's R&D and clinical trials and be used to construct new production bases. The completion of the new production base will significantly improve the application efficiency of the products independently developed by Elite and reduce the cost without reducing the capacity of the products.
Yesterday 05:56 PM
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth